Skip to main content
M

MDExam

MDExam is a telemedicine company offering GLP-1-based weight loss treatment with personalised coaching, medical supervision and home delivery through a virtual care platform in the United States.

MDExam is a telemedicine company that combines GLP-1 medications, coaching and digital health technology to deliver a virtual weight-loss programme to patients across the United States. Operating from Miami, Florida, the company offers care through home-based virtual consultations, with medications delivered to the patient's door and licensed medical professionals providing ongoing supervision.

Its Comprehensive Telehealth Weight Loss Program pairs personalised, evidence-based treatment plans with nutrition guidance, exercise coaching and remote patient monitoring. Treatment plans are tailored to each patient's medical history and individual goals, and are delivered by expert medical professionals working closely with the patient over time. GLP-1 options include Semaglutide-based and Tirzepatide-based treatments. The programme starts at $225 per month and does not require insurance.

MDExam reports having served more than 86,000 patients, with a stated success rate of 93%. The company's stated emphasis is on sustainable, long-term results achieved through the combination of medication, nutrition and exercise coaching rather than medication alone.

1 Open job